Haematologica (Apr 2024)
Hypomethylating agents are associated with high rates of hematologic toxicity in patients with secondary myeloid neoplasms developing after acquired aplastic anemia
- Matthew P. Connor,
- Neeharika Prathapa,
- Noelle V. Frey,
- Saar I. Gill,
- Elizabeth O. Hexner,
- Ximena Jordan Bruno,
- Catherine E. Lai,
- Alison W. Loren,
- Selina M. Luger,
- Andrew H. Matthews,
- Shannon R. McCurdy,
- Alexander E Perl,
- David L. Porter,
- Arlene Zeringue,
- Joseph H. Oved,
- Timothy S. Olson,
- Keith W. Pratz,
- Daria V. Babushok
Affiliations
- Matthew P. Connor
- Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania
- Neeharika Prathapa
- Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania
- Noelle V. Frey
- Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania
- Saar I. Gill
- Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania
- Elizabeth O. Hexner
- Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania
- Ximena Jordan Bruno
- Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania
- Catherine E. Lai
- Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania
- Alison W. Loren
- Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania
- Selina M. Luger
- Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania
- Andrew H. Matthews
- Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania
- Shannon R. McCurdy
- Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania
- Alexander E Perl
- Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania
- David L. Porter
- Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania
- Arlene Zeringue
- Information Services, University of Pennsylvania
- Joseph H. Oved
- Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York City, NY; Comprehensive Bone Marrow Failure Center, Children’s Hospital of Philadelphia
- Timothy S. Olson
- Comprehensive Bone Marrow Failure Center, Children’s Hospital of Philadelphia, Philadelphia, PA; Department of Oncology, Department of Pediatrics, Children’s Hospital of Philadelphia
- Keith W. Pratz
- Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania
- Daria V. Babushok
- Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA; Comprehensive Bone Marrow Failure Center, Children’s Hospital of Philadelphia
- DOI
- https://doi.org/10.3324/haematol.2024.285275
- Journal volume & issue
-
Vol. 999,
no. 1
Abstract
Not available.
